BG105998A - Treatment of certain cancers associated with weight gain - Google Patents

Treatment of certain cancers associated with weight gain

Info

Publication number
BG105998A
BG105998A BG105998A BG10599801A BG105998A BG 105998 A BG105998 A BG 105998A BG 105998 A BG105998 A BG 105998A BG 10599801 A BG10599801 A BG 10599801A BG 105998 A BG105998 A BG 105998A
Authority
BG
Bulgaria
Prior art keywords
cancers associated
treatment
weight gain
certain cancers
cancer
Prior art date
Application number
BG105998A
Other languages
Bulgarian (bg)
Inventor
Carl Mendel
Timothy SEATON
Steve Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BG105998A publication Critical patent/BG105998A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A compound of formula or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for the treating cancers associated with obesity including colon cancer, breast cancer, endometrial cancer and gallbladder cancer. 20 claims
BG105998A 1999-03-19 2001-10-10 Treatment of certain cancers associated with weight gain BG105998A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19
PCT/US2000/007361 WO2000056323A1 (en) 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain

Publications (1)

Publication Number Publication Date
BG105998A true BG105998A (en) 2002-06-28

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105998A BG105998A (en) 1999-03-19 2001-10-10 Treatment of certain cancers associated with weight gain

Country Status (19)

Country Link
EP (1) EP1171106A1 (en)
JP (1) JP2002539255A (en)
KR (1) KR20010113765A (en)
CN (1) CN1399545A (en)
AU (1) AU3632000A (en)
BG (1) BG105998A (en)
BR (1) BR0009161A (en)
CA (1) CA2367045A1 (en)
CZ (1) CZ20013281A3 (en)
HU (1) HUP0200497A2 (en)
IL (1) IL145239A0 (en)
MX (1) MXPA01009470A (en)
NO (1) NO20014478L (en)
NZ (1) NZ514012A (en)
PL (1) PL351958A1 (en)
SK (1) SK13372001A3 (en)
TR (1) TR200102692T2 (en)
WO (1) WO2000056323A1 (en)
ZA (1) ZA200107687B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
TR200102692T2 (en) 2002-03-21
EP1171106A1 (en) 2002-01-16
NZ514012A (en) 2001-09-28
CN1399545A (en) 2003-02-26
PL351958A1 (en) 2003-07-14
CA2367045A1 (en) 2000-09-28
JP2002539255A (en) 2002-11-19
IL145239A0 (en) 2002-06-30
WO2000056323A1 (en) 2000-09-28
SK13372001A3 (en) 2002-07-02
KR20010113765A (en) 2001-12-28
NO20014478L (en) 2001-10-29
NO20014478D0 (en) 2001-09-14
CZ20013281A3 (en) 2002-07-17
HUP0200497A2 (en) 2002-08-28
MXPA01009470A (en) 2004-03-19
AU3632000A (en) 2000-10-09
BR0009161A (en) 2002-01-22
ZA200107687B (en) 2002-12-18

Similar Documents

Publication Publication Date Title
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
MXPA01009404A (en) Method of treating eating disorders.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DE60112974D1 (en) Carbolinderivate
GB0125259D0 (en) Novel compounds
GB0225475D0 (en) Therapeutic agents
PL367682A1 (en) Dolastatin 10 derivatives
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
MXPA04005784A (en) Substituted 2-phenyl benzofurans as estrogenic agents.
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
HK1033574A1 (en) Anitumor agents
WO2000056315A8 (en) Treatment of pain
TW200508199A (en) Novel compound
BG105998A (en) Treatment of certain cancers associated with weight gain
BG105999A (en) Treatment of osteoarthritis
TW200510370A (en) Urea derivatives
MXPA01009469A (en) Treatment to lower platelet adhesiveness.
MXPA01009468A (en) Treatment of pulmonary hypertension.
MXPA01009463A (en) Treatment of hiatial hernia.
MXPA01009462A (en) Treatment of gallstones.
MXPA01009465A (en) Weight loss after pregnancy.
BG105996A (en) Method of treating eating disorders
JO2301B1 (en) Process for preparing Neuraminidase inhibitor RO-64-0796